Aktive Positionen von Benjamin Li
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
China Oncology Focus Ltd.
 China Oncology Focus Ltd. Pharmaceuticals: MajorHealth Technology China Oncology Focus Ltd. operates as a drug development company. The firm specializes in oncology disease area. The company is headquartered in Road Town, British Virgin Islands. | Vorstandsvorsitzender | - | - |
Zhaoke (Hong Kong) Ophthalmology Pharmaceutical Ltd.
 Zhaoke (Hong Kong) Ophthalmology Pharmaceutical Ltd. Pharmaceuticals: MajorHealth Technology Zhaoke (Hong Kong) Ophthalmology Pharmaceutical Ltd. engages in the development of eye treatment. It also focuses on licensing potential ophthalmology products and introduce it as accessible and affordable therapies to patients suffering from ophthalmic diseases in China. The company was founded on July 24, 2017 and is headquartered in Hong Kong. | Vorsitzender | - | - |
Karriereverlauf von Benjamin Li
Statistik
International
| Hong Kong | 2 |
Operativ
| Chief Executive Officer | 1 |
| Chairman | 1 |
Sektoral
| Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
China Oncology Focus Ltd.
China Oncology Focus Ltd. Pharmaceuticals: MajorHealth Technology China Oncology Focus Ltd. operates as a drug development company. The firm specializes in oncology disease area. The company is headquartered in Road Town, British Virgin Islands. | Health Technology |
Zhaoke (Hong Kong) Ophthalmology Pharmaceutical Ltd.
Zhaoke (Hong Kong) Ophthalmology Pharmaceutical Ltd. Pharmaceuticals: MajorHealth Technology Zhaoke (Hong Kong) Ophthalmology Pharmaceutical Ltd. engages in the development of eye treatment. It also focuses on licensing potential ophthalmology products and introduce it as accessible and affordable therapies to patients suffering from ophthalmic diseases in China. The company was founded on July 24, 2017 and is headquartered in Hong Kong. | Health Technology |
- Börse
- Insiders
- Benjamin Li
- Erfahrung
